Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Conditions
Medulloblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Lucille Packard Children's Hospital Stanford, Palo Alto, California, United States
Contact: Principal Investigator (Sonia Partap, MD, MS)Orlando Health Arnold Palmer Hospital for Children, Orlando, Florida, United States
Contact: Principal Investigator (Avery Wright, DO)St. Joseph's Children's Hospital, Tampa, Florida, United States
Contact: Principal Investigator (Trisha Larkin, MD)C.S. MOTT Children's Hospital, University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Santhosh Upadhyaya, MD)Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Anne Bendel, MD)St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Giles W. Robinson, MD)Contact: Principal Investigator (Aditi Bagchi, MD, PhD)UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas, Texas, United States
Contact: Principal Investigator (Daniel Bowers, MD)Cook Children's Medical Center, Fort Worth, Texas, United States
Contact: Principal Investigator (Sibo Zhao, MD)Texas Children's Hospital, Houston, Texas, United States
Contact: Principal Investigator (Murali Chintagumpala, MD)Primary Children's Hospital, Salt Lake City, Utah, United States
Contact: Principal Investigator (Nicholas Whipple, MD)
Study leads
Giles W. Robinson, MD
Principal Investigator
St. Jude Children's Research Hospital
Aditi Bagchi, MD, PhD
Principal Investigator
St. Jude Children's Research Hospital